Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

VTV THERAPEUTICS INC.

(VTVT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Slip Pre-Bell Friday

09/24/2021 | 09:15am EDT


© MT Newswires 2021
All news about VTV THERAPEUTICS INC.
09:42aVTV THERAPEUTICS : Names Deepa Prasad CEO, President
MT
09:11aVTV THERAPEUTICS : Announces Deepa Prasad as New President and CEO - Form 8-K
PU
09:02aVTV THERAPEUTICS INC. : Change in Directors or Principal Officers, Financial Statements an..
AQ
09:01aVTV THERAPEUTICS : Announces Deepa Prasad as New President and CEO
PR
10/12VTV THERAPEUTICS' : Diabetes Drug Trial Achieves Primary Endpoint
MT
10/12vTv Therapeutics Announces Positive Results from Mechanistic Study Indicating No Increa..
GL
10/12VTV THERAPEUTICS : Announces Positive Results from Mechanistic Study Indicating No Increas..
GL
10/12VTv Therapeutics Announces Positive Results from Mechanistic Study Indicating No Increa..
CI
09/24Health Care Stocks Retreat Friday
MT
09/24Health Care Stocks Slip Pre-Bell Friday
MT
More news
Financials (USD)
Sales 2021 3,00 M - -
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 88,5 M 88,5 M -
Capi. / Sales 2021 29,5x
Capi. / Sales 2022 88,5x
Nbr of Employees 25
Free-Float 28,2%
Chart VTV THERAPEUTICS INC.
Duration : Period :
vTv Therapeutics Inc. Technical Analysis Chart | VTVT | US9183851057 | MarketScreener
Technical analysis trends VTV THERAPEUTICS INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 1,47 $
Average target price 6,75 $
Spread / Average Target 359%
Managers and Directors
Stephen L. Holcombe President & Chief Executive Officer
Rudy C. Howard EVP, Chief Financial & Accounting Officer
Robin E. Abrams Executive Chairman
Aaron H. Burstein Senior Vice President-Clinical Development
Carmen Valcarce Chief Scientific Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
VTV THERAPEUTICS INC.-20.97%88
GILEAD SCIENCES, INC.14.76%83 880
WUXI APPTEC CO., LTD.25.14%66 875
BIONTECH SE230.50%63 484
REGENERON PHARMACEUTICALS16.48%57 402
VERTEX PHARMACEUTICALS-21.52%48 101